![Allosteric Regulation of BH3 Proteins in Bcl-xL Complexes Enables Switch-like Activation of Bax - ScienceDirect Allosteric Regulation of BH3 Proteins in Bcl-xL Complexes Enables Switch-like Activation of Bax - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1097276519309554-fx1.jpg)
Allosteric Regulation of BH3 Proteins in Bcl-xL Complexes Enables Switch-like Activation of Bax - ScienceDirect
![Selective targeting of antiapoptotic BCL‐2 proteins in cancer - Timucin - 2019 - Medicinal Research Reviews - Wiley Online Library Selective targeting of antiapoptotic BCL‐2 proteins in cancer - Timucin - 2019 - Medicinal Research Reviews - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4332d89b-c0df-4927-9e26-daedbefd05ad/med21516-fig-0003-m.jpg)
Selective targeting of antiapoptotic BCL‐2 proteins in cancer - Timucin - 2019 - Medicinal Research Reviews - Wiley Online Library
![NOXA-dependent contextual synthetic lethality of BCL-XL inhibition and “osmotic reprogramming” in colorectal cancer | Cell Death & Disease NOXA-dependent contextual synthetic lethality of BCL-XL inhibition and “osmotic reprogramming” in colorectal cancer | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-020-2446-8/MediaObjects/41419_2020_2446_Fig1_HTML.png)
NOXA-dependent contextual synthetic lethality of BCL-XL inhibition and “osmotic reprogramming” in colorectal cancer | Cell Death & Disease
![Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells - Journal of Biological Chemistry Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/ea3ce840-3177-4a26-928d-87bf47dca279/gr1.jpg)
Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells - Journal of Biological Chemistry
![Why do BCL-2 inhibitors work and where should we use them in the clinic? | Cell Death & Differentiation Why do BCL-2 inhibitors work and where should we use them in the clinic? | Cell Death & Differentiation](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fcdd.2017.183/MediaObjects/41418_2018_Article_BFcdd2017183_Fig1_HTML.jpg)
Why do BCL-2 inhibitors work and where should we use them in the clinic? | Cell Death & Differentiation
![Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity - ScienceDirect Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X16302529-gr5.jpg)
Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity - ScienceDirect
![Bcl-2 and Bcl-xL Inhibit CD95-mediated Apoptosis by Preventing Mitochondrial Release of Smac/DIABLO and Subsequent Inactivation of X-linked Inhibitor-of-Apoptosis Protein* - Journal of Biological Chemistry Bcl-2 and Bcl-xL Inhibit CD95-mediated Apoptosis by Preventing Mitochondrial Release of Smac/DIABLO and Subsequent Inactivation of X-linked Inhibitor-of-Apoptosis Protein* - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/3998f0e3-c190-4b0d-90e4-44ce3e4222a4/gr1.jpg)
Bcl-2 and Bcl-xL Inhibit CD95-mediated Apoptosis by Preventing Mitochondrial Release of Smac/DIABLO and Subsequent Inactivation of X-linked Inhibitor-of-Apoptosis Protein* - Journal of Biological Chemistry
![Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy | Science Translational Medicine Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy | Science Translational Medicine](https://stm.sciencemag.org/content/scitransmed/7/279/279ra40/F1.large.jpg)
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy | Science Translational Medicine
![Selective targeting of antiapoptotic BCL‐2 proteins in cancer - Timucin - 2019 - Medicinal Research Reviews - Wiley Online Library Selective targeting of antiapoptotic BCL‐2 proteins in cancer - Timucin - 2019 - Medicinal Research Reviews - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1494bb2f-a60e-491e-951f-7f9680dc0230/med21516-fig-0005-m.jpg)
Selective targeting of antiapoptotic BCL‐2 proteins in cancer - Timucin - 2019 - Medicinal Research Reviews - Wiley Online Library
BH3 mimetics (2). (A) BCL-XL and BCL-2 inhibitor derived from ABT-737;... | Download Scientific Diagram
![Co-inhibition of BCL-XL and MCL-1 with BCL-2 selective inhibitors A1331852 and S63845 enhances cytotoxicity of cervical cancer cell lines | bioRxiv Co-inhibition of BCL-XL and MCL-1 with BCL-2 selective inhibitors A1331852 and S63845 enhances cytotoxicity of cervical cancer cell lines | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2019/10/30/824649/F4.large.jpg)
Co-inhibition of BCL-XL and MCL-1 with BCL-2 selective inhibitors A1331852 and S63845 enhances cytotoxicity of cervical cancer cell lines | bioRxiv
![IJMS | Free Full-Text | BCL-xL, a Mitochondrial Protein Involved in Successful Aging: From C. elegans to Human Centenarians | HTML IJMS | Free Full-Text | BCL-xL, a Mitochondrial Protein Involved in Successful Aging: From C. elegans to Human Centenarians | HTML](https://www.mdpi.com/ijms/ijms-21-00418/article_deploy/html/images/ijms-21-00418-g001.png)
IJMS | Free Full-Text | BCL-xL, a Mitochondrial Protein Involved in Successful Aging: From C. elegans to Human Centenarians | HTML
![The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production.,Oncogene - X-MOL The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production.,Oncogene - X-MOL](https://xpic.x-mol.com/20200218%2F10.1038_s41388-020-1212-9.png)